61 – 70 of 3220
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Sweet Aging : Glycocalyx and Galectins in CNS Aging and Neurodegenerative Disorders
- Contribution to journal › Scientific review
-
Mark
Apathy and affective symptoms associated with elevated plasma neurofilament light but not p-tau181 in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2/3 agonist and L-DOPA treatment
- Contribution to journal › Article
-
Mark
The Alzheimer's Association Global Biomarker Standardization Consortium (GBSC) plasma phospho-tau Round Robin study
- Contribution to journal › Article
-
Mark
Toward a biological definition of neuronal and glial synucleinopathies
- Contribution to journal › Article
-
Mark
Modeling Sporadic Progressive Supranuclear Palsy in 3D Midbrain Organoids : Recapitulating Disease Features for In Vitro Diagnosis and Drug Discovery
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid circulation and the glymphatic system in health and disease
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2025:59
- Thesis › Doctoral thesis (compilation)
-
Mark
evoke and evoke+ : design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer’s disease
- Contribution to journal › Article
-
Mark
Fear extinction retention in children, adolescents, and adults
- Contribution to journal › Article
-
Mark
Increased plasma DOPA decarboxylase levels in Lewy body disorders are driven by dopaminergic treatment
- Contribution to journal › Article
